![John McDonald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John McDonald
Director/Board Member at
GERON CORPORATION
Net worth: - $ as of 2026-05-30
Profile
John F.
McDonald is the founder of Solasia Pharma KK, founded in 2006.
Current jobs include Independent Director at Geron Corp.
since 2022, Independent Director at Nouscom AG since 2018, Director at Nouscom Srl, and Vice President, Global Head-Business Development, M&A at Novo Nordisk A since 2018.
Former jobs include Director at CalciMedica Subsidiary, Inc., Managing Director at MPM BioImpact LLC, Vice President-Business Development at Millennium Pharmaceuticals, Inc., Vice President-Business Development at Biogen, Inc. from 2011 to 2018, and Principal at Genzyme Corp.
Education includes graduate studies at the University of California, Hastings, and undergraduate and Masters of Business Administration degrees from Haas School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GERON CORPORATION -.--% | 2026-05-19 | 0 ( -.--% ) | - $ | 2026-05-30 |
John McDonald active positions
| Companies | Position | Start |
|---|---|---|
| GERON CORPORATION | Director/Board Member | 2022-09-06 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 2018-09-30 |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Director/Board Member | 2018-11-04 |
Nouscom Srl
 Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer | Director/Board Member | - |
Former positions of John McDonald
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 2018-08-31 |
CalciMedica Subsidiary, Inc.
 CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Director/Board Member | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| SOLASIA PHARMA K.K. | Founder | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
Training of John McDonald
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
CalciMedica Subsidiary, Inc.
CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Health Technology |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
University of California, Hastings
 University of California, Hastings Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solasia Pharma KK
 Solasia Pharma KK Pharmaceuticals: MajorHealth Technology Engages in the development, sale, import and export of pharmaceutical products and medical devices | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Health Technology |
Nouscom Srl
Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer | Commercial Services |
- Stock Market
- Insiders
- John McDonald
